HTR1A and schizophrenia: Antagonism of 5-HT1A receptor has been shown to ameliorate cognitive impairment in AD and schizophrenia (Meltzer and Sumiyoshi, 2008; Ogren et al., 2008; Shimizu et al., 2013).